How do you pay?

How to pay the least

Ask for the cash price

Avmapki Fakzynja Co-Pack

We didn’t find one.

What to do

  1. Ask your pharmacy for Avmapki Fakzynja Co-Pack’s cash price, and one or two other pharmacies too.

Compare every option

Brand name

Avmapki Fakzynja Co-Pack, the original

Cash priceAsk the pharmacy

We didn’t find a savings card or cash price from Avmapki Fakzynja Co-Pack’s maker. Ask the pharmacy for Avmapki Fakzynja Co-Pack’s cash price. With insurance, ask what your plan charges.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

We didn’t find one.

Not soldNone found

What it’s used for

What the FDA label says

AVMAPKI FAKZYNJA CO-PACK, a combination of avutometinib and defactinib, each kinase inhibitors, is indicated for the treatment of adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior systemic therapy.

This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Source: the FDA label for Avmapki Fakzynja Co-Pack (Verastem Inc.), May 1, 2025. Full label on DailyMed 

Good to know

  • We didn’t find a savings card from Avmapki Fakzynja Co-Pack’s maker.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.